# Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies

> **NCT01602627** · PHASE1 · TERMINATED · sponsor: **Dale Shepard, MD, PhD** · enrollment: 2 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** Hsp90 inhibitor AUY922
- **OTHER:** pharmacological study
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01602627
- **Lead sponsor:** Dale Shepard, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-09
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2013-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01602627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01602627, "Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01602627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*